Roche provides update on Tecentriq US indication for PD-L1-positive, metastatic triple-negative breast cancer

Basel, 27 August 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the company has made the decision to voluntarily withdraw the US accelerated approval for Tecentriq® (atezolizumab) in combination with chemotherapy (Abraxane®, albumin-bound paclitaxel; nab-paclitaxel) for the treatment of adults with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) whose tumours... Read more

Shimadzu has released the DPiMS QT

The DPiMS QT probe electrospray ionization kit is attached to a quadrupole time-of-flight MS. The probe allows extremely small sample volumes to be selected and introduced into the MS unit for analysis. The DPiMS QT is a direct ionization interface unit that makes it simple for users to switch to ESI. Read more

Xylem 2021 Investor Day to be Held Virtually

RYE BROOK, N.Y.–(BUSINESS WIRE)–Aug. 26, 2021– Xylem, Inc. (NYSE: XYL), a leading global water technology company, today announced the format of its 2021 Investor Day will be virtual, in response to emerging public health guidance in relation to COVID-19. The event will be held as previously announced on September 30 beginning at 8:30 am, U.S.... Read more

Young Scientist Develops Neurodegenerative Disease Screening

We already introduced Neha Mani, the winner of the Regeneron International Science and Engineering Fair 2021 in Applied Microbiology. Ron Nachum was awarded in the category of Disease Detection and Diagnosis and therefore also received a ZEISS Primostar 3 microscope donation. Ron is a senior at Thomas Jefferson High School for Science and Technology (Virginia, USA).... Read more

FDA Approves NGS-Based Companion Diagnostic for Previously Treated IDH1-Mutated Cholangiocarcinoma

FDA Approves NGS-Based Companion Diagnostic for Previously Treated IDH1-Mutated Cholangiocarcinoma CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO CARLSBAD, Calif., Aug. 25, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted pre-market approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to... Read more

Divestment of NDC Technologies

24 August 2021 – Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, today announces the divestment of its NDC Technologies (‘NDC’) business. The transaction is in line with Spectris’ strategy to simplify and focus its portfolio and is the last of the divestments identified in 2019 as part of its Strategy... Read more

Danaher Announces Human Resources And Accounting Leadership Transition Plans

WASHINGTON, Aug. 24, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced that, effective April 1, 2022, Georgeann F. Couchara will succeed Angela S. Lalor as Senior Vice President, Human Resources. At that time, Ms. Lalor will move to a part time, advisory role until her retirement in the first quarter of 2023. Ms. Couchara, currently Vice President,... Read more

PerkinElmer to Present at 2021 Baird Global Healthcare Conference

WALTHAM, Mass.–(BUSINESS WIRE)–Aug. 24, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the virtual Baird Global Healthcare Conference on Tuesday, September 14, 2021 at 10:50 a.m. ET. Steve Willoughby, vice president of investor relations of PerkinElmer, will provide an update... Read more

Shimadzu has released Py-Screener Ver.2

Screening System for Phthalate Esters and Brominated Flame Retardants Making the Difficult simple Py-Screener™ Ver. 2 is designed to screen for brominated flame retardants, such as PBBs and PBDEs, and phthalate esters in polymers. These substances are regulated under the Directive on the restriction of the use of certain hazardous substances in electrical and electronic... Read more